Literature DB >> 8163950

Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses.

F Temoltzin-Palacios1, D B Thomas.   

Abstract

The regions of antigenic variation in influenza hemagglutinin (HA) are located on surface-accessible regions in the three-dimensional structure of the HA1 monomer. The aim of this study was to establish whether a novel variant virus, IMUT4, in which we had mutated specific amino acid residues (HA1 63, 144, 158, and 193) in these regions, previously shown to be immunodominant for CBA/Ca mice, would either (a) establish holes in the antibody (ab) repertoire or (b) preclude further antigenic variation in IMUT4. CBA/Ca mice were able to mount a neutralizing ab response to IMUT4 infection and molecular recognition sites were established by sequencing of the HA genes of monoclonal antibody (mAb)-selected laboratory variants of wild-type X31 virus (HA1 131, 145, 155, and 196). However, each of these mAbs failed to select further antigenic variants of IMUT4, in ovo, but rather a receptor binding mutant (HA1 190 Glu-->Asp; 226 Leu-->Gln) that was still recognized by the selecting mAb, specific for HA1 155 of X31 virus. The facility for antigenic variation in influenza would appear to be compromised, therefore, by targeted mutation of immunodominant sites, as initially proposed by S. Fazekas de St. Groth (Fazekas de St. Groth, S. 1977. Antigenic, adaptive and adsorptive variants of the influenza haemagglutinin. In Topics in Infectious Diseases. Vol. 3. R.G. Laver, H. Bachmayer, and R. Weil, editors. Springer-Verlag, Vienna. 25-48.). It is interesting to note that recent isolates of the H3 subtype, (e.g., A/Beijing/92) obtained between 1991 and 1993, contain the same substitutions at HA1 190 and 226, which may indicate similar constraints to immune evasion and the relevance of our findings to antigenic variation in the human population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163950      PMCID: PMC2191490          DOI: 10.1084/jem.179.5.1719

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Antigenic drift in type A influenza virus: sequence differences in the hemagglutinin of Hong Kong (H3N2) variants selected with monoclonal hybridoma antibodies.

Authors:  W G Laver; G M Air; R G Webster; W Gerhard; C W Ward; T A Dopheide
Journal:  Virology       Date:  1979-10-15       Impact factor: 3.616

2.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

3.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

4.  Antigenic analyses of influenza virus haemagglutinins with different receptor-binding specificities.

Authors:  R S Daniels; A R Douglas; J J Skehel; D C Wiley; C W Naeve; R G Webster; G N Rogers; J C Paulson
Journal:  Virology       Date:  1984-10-15       Impact factor: 3.616

5.  Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites.

Authors:  G W Both; M J Sleigh; N J Cox; A P Kendal
Journal:  J Virol       Date:  1983-10       Impact factor: 5.103

6.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

7.  Antigenic and amino acid sequence analyses of influenza viruses of the H1N1 subtype isolated between 1982 and 1984.

Authors:  R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

8.  Analyses of the antigenicity of influenza haemagglutinin at the pH optimum for virus-mediated membrane fusion.

Authors:  R S Daniels; A R Douglas; J J Skehel; D C Wiley
Journal:  J Gen Virol       Date:  1983-08       Impact factor: 3.891

9.  Evolution of the Hong Kong influenza A sub-type. Structural relationships between the haemagglutinin from A/duck/Ukraine/1/63 (Hav 7) and the Hong Kong (H3) haemagglutinins.

Authors:  C W Ward; T A Dopheide
Journal:  Biochem J       Date:  1981-04-01       Impact factor: 3.857

10.  Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin.

Authors:  C A Smith; B C Barnett; D B Thomas; F Temoltzin-Palacios
Journal:  J Exp Med       Date:  1991-04-01       Impact factor: 14.307

View more
  11 in total

1.  Diverse antigenic site targeting of influenza hemagglutinin in the murine antibody recall response to A(H1N1)pdm09 virus.

Authors:  Jason R Wilson; Zhu Guo; Wen-Pin Tzeng; Rebecca J Garten; Xu Xiyan; Elisabeth G Blanchard; Kristy Blanchfield; James Stevens; Jacqueline M Katz; Ian A York
Journal:  Virology       Date:  2015-08-27       Impact factor: 3.616

2.  Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution.

Authors:  Arthur Chun-Chieh Shih; Tzu-Chang Hsiao; Mei-Shang Ho; Wen-Hsiung Li
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-29       Impact factor: 11.205

3.  Diversity of the murine antibody response targeting influenza A(H1N1pdm09) hemagglutinin.

Authors:  Jason R Wilson; Wen-Pin Tzeng; April Spesock; Nedzad Music; Zhu Guo; Robert Barrington; James Stevens; Ruben O Donis; Jacqueline M Katz; Ian A York
Journal:  Virology       Date:  2014-05-10       Impact factor: 3.616

Review 4.  Why Glycosylation Matters in Building a Better Flu Vaccine.

Authors:  Deborah Chang; Joseph Zaia
Journal:  Mol Cell Proteomics       Date:  2019-10-11       Impact factor: 5.911

5.  Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigene.

Authors:  S Laeeq; C A Smith; S D Wagner; D B Thomas
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 6.  Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Authors:  Karlynn E Neu; Carole J Henry Dunand; Patrick C Wilson
Journal:  Curr Opin Immunol       Date:  2016-06-03       Impact factor: 7.486

7.  Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render influenza A virus (H3) candidate vaccine ineffective.

Authors:  S Kodihalli; D M Justewicz; L V Gubareva; R G Webster
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses.

Authors:  Lyubov Popova; Kenneth Smith; Ann H West; Patrick C Wilson; Judith A James; Linda F Thompson; Gillian M Air
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

9.  Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.

Authors:  M Matrosovich; P Gao; Y Kawaoka
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

10.  Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs.

Authors:  Ivan Kosik; William L Ince; Lauren E Gentles; Andrew J Oler; Martina Kosikova; Matthew Angel; Javier G Magadán; Hang Xie; Christopher B Brooke; Jonathan W Yewdell
Journal:  PLoS Pathog       Date:  2018-01-18       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.